Study of dexmedetomidine for hard-to-treat cancer pain
Part of Brain & nervous system, Cancer, Pain clinical trials.
This study tests a medication called dexmedetomidine for people with advanced cancer who have severe pain that is not relieved by usual pain medicines. Dexmedetomidine is a sedative that may help control pain when other options don't work.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have cancer that is not being treated with the goal of a cure.
- You have cancer-related pain that is not controlled by standard painkillers, with a pain score of more than 4 out of 10.
- You are currently receiving strong opioid painkillers (like morphine) through an IV or a patch.
- You do not have serious heart or liver problems, very low blood pressure, or a very slow heart rate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether dexmedetomidine can reduce pain after elective shoulder arthroscopy surgery done under general anesthesia. If you’re eligible, it may help improve postoperative comfort and reduce the need for additional pain treatment.
This study tests whether adding a medicine called dexmedetomidine to a nerve block (an injection near the spine) can improve pain relief after kidney stone surgery. It is for people who are generally healthy and scheduled for a kidney stone procedure.
This trial studies whether adding a medication called dexmedetomidine during cancer surgery can improve long-term survival. It is for older adults having major cancer surgery that lasts at least two hours and who will need a pain pump after the operation.
This study tests whether adding a sedative medicine to the numbing medication used in a nerve block can improve pain relief after upper abdominal cancer surgery. It may help reduce pain and the need for strong painkillers after the operation.
This trial studies a two-part pain pump given through a vein during major laparoscopic abdominal surgery to help control pain with general anesthesia. It may help by improving comfort while also avoiding certain side effects for people who can safely receive the study medicine.
This study tests whether adding a medication called dexmedetomidine to the standard numbing medicine (bupivacaine) in a pain block after lower abdominal cancer surgery can improve pain relief. It compares two different doses of the added medication to see which works better.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.